Clinical Trial Update: Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical Trial [NA]

View source ↗

Summary

A randomized, parallel-controlled study assessing the effects of Henagliflozin on brain function in patients with Type 2 Diabetes Mellitus and Mild Cognitive Im…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Type 2 Diabetes Mellitus

Drugs mentioned

• Henagliflozin (henagliflozin)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Type 2 Diabetes Mellitus, Mild Cognitive Impairment | NA | Status: COMPLETED